Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Objective: To investigate the association between neuroleptic malignant syndrome (NMS) and levels of antipsychotic exposure. Method: Electronic health record data systematically screened from a large mental health service provider in southeast London provided 67 NMS cases which were individually matched with 254 controls on age, gender, and primary psychiatric diagnosis. Data on psychotropic agents, combinations, dose, and dose change of antipsychotic prescriptions over the preceding 5 (oral agents) or 15 days (depot agents) were extracted and compared between groups using conditional logistic regression models. Results: NMS was associated with higher number of antipsychotic agents used, use of first‐generation agents or aripiprazole, use of first‐generation agents only or cross‐generation agents, and higher mean and maximum daily doses. In further analyses, associations with antipsychotics type remained significant when adjusted for dose, but those with dose were attenuated following adjustment for type. The specific use of haloperidol, aripiprazole, depot flupentixol, and benzodiazepines was independently associated with NMS. Non‐white ethnicity was also found to be associated with NMS. Conclusion: NMS was primarily associated with type of antipsychotic and polypharmacy rather than overall dose. Variation in risk by ethnicity requires further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Mailman, R., & Murthy, V. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361461 · Cited by 311
Cited by
Management of common adverse effects of antipsychotic medications
Stroup, T. S., & Gray, N. (2018) · World Psychiatry · doi:10.1002/wps.20567 · Cited by 572
Perera, G., Broadbent, M., Callard, F., Chang, C.-K., Downs, J., Dutta, R., Fernandes, A., Hayes, R. D., Henderson, M., Jackson, R., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-008721 · Cited by 492
Self-citationThermoregulatory disorders and illness related to heat and cold stress
Cheshire, W. P. (2016) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.01.001 · Cited by 349
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Tse, L., Barr, A., Scarapicchia, V., & Vila-Rodriguez, F. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13999150424113345 · Cited by 179
“Lastly, there are also anecdotal reports that describe polypharmacy as a risk factor for NMS [27].”
BackgroundSarkar, S., & Gupta, N. (2017) · BJPsych Bulletin · doi:10.1192/pb.bp.116.053736 · Cited by 38
Metadata
- Authors
- Su, Y. ‐., Chang, C. ‐., Hayes, R. D., Harrison, S., Lee, W., Broadbent, M., Taylor, D., & Stewart, R.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2013-11-15
- Volume
- 130
- Issue
- 1
- Pages
- 52-60
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2158322055
- Cited by
- 67
- References
- 1
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome. https://app.cochat.ai/papers/10.1111/acps.12222
- The paper
- Su, Y. ‐., Chang, C. ‐., Hayes, R. D., Harrison, S., Lee, W., Broadbent, M., Taylor, D., & Stewart, R. (2014). Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12222
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.